comprehensive -WSS

comprehensive

author：comprehensive 2025-09-08 11:04:56 - browse：7

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

focus

WSS

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

White House calls on federal agencies to crack down on AI abuses

Victims of gun violence feel impacts long after bullet wound

Morgan Health, with ambitious aims, wants you to know it’s still here

U.K. sequencing study surfaces new findings about tumor DNA

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

leisure time

comprehensive

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

DIEP, the 'gold standard' of breast reconstruction, is under threat

Free speech concerns arise in wake of journal editor Eisen's firing

Continuity nursing helped my family in our darkest PICU moments

FDA approves potent Eli Lilly obesity drug, Zepbound

Affirmative action in medical school literally saved lives

UCB departs biotech trade group BIO

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The FDA must approve intranasal treatments for anaphylaxis

hotspot

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Antibiotic resistance and the global rise in human conflict

Why psychiatrists like me stop taking insurance

FDA approves Recor Medical high blood pressure device

Biotech incubator Curie.Bio graduates its first startup

entertainment

focus

knowledge

knowledge